Corcept Therapeutics
Pharmaceutical & medical device company payment data from CMS Open Payments.
Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Unspecified | $13.3M | 2,168 | 50.3% |
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $4.7M | 2,168 | 17.7% |
| Food and Beverage | $2.6M | 102,336 | 10.0% |
| Consulting Fee | $2.6M | 1,135 | 9.9% |
| Travel and Lodging | $1.5M | 3,875 | 5.8% |
| Honoraria | $1.4M | 560 | 5.4% |
| Grant | $152,052 | 21 | 0.6% |
| Space rental or facility fees (teaching hospital only) | $77,030 | 35 | 0.3% |
| Education | $13,491 | 605 | 0.1% |
| Compensation for serving as faculty or as a speaker for a medical education program | $7,930 | 6 | 0.0% |
| Compensation for serving as faculty or as a speaker for an accredited or certified continuing education program | $3,500 | 1 | 0.0% |
Payments by Type
Research Studies & Clinical Trials
| Study Name | Total Paid | Doctors | Records |
|---|---|---|---|
| CORT125134-552 | $3.3M | 0 | 210 |
| CORT125134-550 | $2.9M | 0 | 71 |
| Study 550 | $2.5M | 0 | 63 |
| CORT125134-455 | $1.1M | 0 | 441 |
| CORT125281-601 | $858,185 | 0 | 171 |
| CORT118335-876 | $476,204 | 0 | 153 |
| CORT125134-452 | $383,402 | 0 | 107 |
| Study 500 | $224,230 | 0 | 19 |
| Study 451 | $197,382 | 0 | 27 |
| Study 700 | $174,731 | 0 | 11 |
| CORT125134-456 | $165,233 | 0 | 56 |
| CORT118335-877 | $132,430 | 0 | 42 |
| C1073-500 Phase 1 Study of Mifepristone in Combination with Eribulin in Patients with Locally AdvancedMetastatic Breast Cancer or Other Specified Solid Tumors, with a Dose Expansion Cohort in Patients with Triple Negative Breast Cancer | $130,132 | 0 | 5 |
| CORT125134-551 | $124,841 | 0 | 4 |
| CORT125134-553 | $85,048 | 0 | 19 |
| CORT125134-451 Cushing's Syndrome | $84,948 | 0 | 20 |
| FKBP5-700 | $73,069 | 0 | 5 |
| CORT125134-451 | $71,146 | 0 | 16 |
| MONARCH STUDY 862 | $67,174 | 33 | 310 |
| Study 601 | $63,315 | 0 | 10 |
| Study 860 | $35,700 | 0 | 2 |
| CATALYST | $33,568 | 22 | 167 |
| Study 455 | $28,372 | 16 | 126 |
| C1073-38 | $26,769 | 0 | 1 |
| CORT 125134-451 | $21,623 | 0 | 2 |
| C1073-500 | $13,964 | 0 | 2 |
| Phase 2 Study of the Safety and Efficacy of CORT125134 in the Treatment of Endogenous Cushing's Syndrome | $12,520 | 0 | 1 |
| Study 876 | $12,095 | 10 | 69 |
| CORT FKBP5-700 | $11,277 | 0 | 1 |
| STOMP-CSC | $7,500 | 0 | 1 |
Payments by Medical Specialty
Top Paid Doctors
| Doctor | Specialty | Location | Total | 2024 |
|---|---|---|---|---|
| Dr. Hanford Yau, M.d, M.D | Endocrinology, Diabetes & Metabolism | Orlando, FL | $561,052 | $0 |
| Kevin Pantalone, D.o, D.O | Endocrinology, Diabetes & Metabolism | Cleveland, OH | $357,431 | $0 |
| Honey East, Md, MD | Endocrinology, Diabetes & Metabolism | Jackson, MS | $331,241 | $0 |
| Alison Gracom, Pa, PA | Medical | Irvine, CA | $325,269 | $0 |
| Elena Christofides, Md, Face, MD, FACE | Endocrinology, Diabetes & Metabolism | Columbus, OH | $322,496 | $0 |
| Bradley Eilerman, Md, MD | Endocrinology, Diabetes & Metabolism | Florence, KY | $290,678 | $0 |
| Dr. David Brown, Md, Phd, MD, PHD | Endocrinology, Diabetes & Metabolism | Rockville, MD | $287,837 | $0 |
| Dr. Eduardo Luna, M.d, M.D | Internal Medicine | Edinburg, TX | $259,978 | $0 |
| Robin Anderson, Np-C, NP-C | Family | Portage, IN | $250,796 | $0 |
| Dr. Matthew Young, Md, MD | Family Medicine | Colorado Springs, CO | $227,213 | $0 |
| Dr. Christopher Lucci, Md, MD | Public Health & General Preventive Medicine | Rockport, TX | $220,123 | $0 |
| Jonathan Ownby, M.d, M.D | Endocrinology, Diabetes & Metabolism | Atlanta, GA | $217,384 | $0 |
| Dr. Peter Butler, M.d, M.D | Endocrinology, Diabetes & Metabolism | Florence, MA | $216,175 | $0 |
| Jennifer Williams, Np, NP | Family | Hendersonville, TN | $208,414 | $0 |
| Dr. Laura Knecht, M.d, M.D | Endocrinology, Diabetes & Metabolism | Cave Creek, AZ | $192,065 | $0 |
| Saleemah Fahmi, Md, MD | Endocrinology, Diabetes & Metabolism | Dallas, TX | $186,830 | $0 |
| Dr. Joseph Mathews, M.d, M.D | Endocrinology, Diabetes & Metabolism | Summerville, SC | $174,641 | $0 |
| Michael Valitutto, Do, DO | Internal Medicine | Kalamazoo, MI | $161,650 | $0 |
| Dr. Rocio Harbison, Md, MD | Endocrinology, Diabetes & Metabolism | Houston, TX | $161,553 | $0 |
| Dr. Allan Kennedy, Md, MD | Endocrinology, Diabetes & Metabolism | Cleveland, OH | $144,429 | $0 |
| Philip Rabito, M.d, M.D | Specialist | New York, NY | $136,307 | $0 |
| Unknown Provider | — | — | $135,339 | $0 |
| Dr. Jerry Back, Md, MD | Internal Medicine | North Charleston, SC | $130,428 | $0 |
| Todd Frieze, Md, MD | Endocrinology, Diabetes & Metabolism | Durham, NC | $123,994 | $0 |
| Ralph Defronzo, Md, MD | Endocrinology, Diabetes & Metabolism | San Antonio, TX | $120,472 | $0 |
About Corcept Therapeutics
Corcept Therapeutics has made $26.5M in payments to 20,973 healthcare providers, recorded across 112,910 transactions in the CMS Open Payments database. In 2024, the company paid $4.2M. The top product by payment volume is Korlym ($17.3M).
Payments were distributed across 184 medical specialties. The top specialty by payment amount is Endocrinology, Diabetes & Metabolism ($7.3M to 2,656 doctors).
Payment categories include: Food & Beverage ($2.6M), Consulting ($2.6M), Research ($13.3M), Travel & Lodging ($1.5M).
Corcept Therapeutics is associated with 1 products in the CMS Open Payments database.